TSW
AXGN icon

Thompson Siegel & Walmsley’s Axogen AXGN Stock Holding History

Thompson Siegel & Walmsley’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,789
Closed -$50K – 748
2020
Q4 		$50K Buy
+2,789
New +$41K ﹤0.01% 448

Other funds holding AXGN

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thompson Siegel & Walmsley's AXGN Position: Q1 2021 in Review

Thompson Siegel & Walmsley sold out of Axogen (AXGN) in Q1 2021, closing a stake of 2,789 shares — an estimated $50K sold.

Thompson Siegel & Walmsley first reported a position in AXGN in Q4 2020 and held it in 1 quarter. The position peaked at $50K in Q4 2020. 123 funds tracked by Wall St. Rank hold AXGN as of Q1 2021.

  • Thompson Siegel & Walmsley reported no remaining Axogen position as of Q1 2021 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 2,789 Axogen shares in Q1 2021, an estimated $50K.
  • Thompson Siegel & Walmsley first reported a position in Axogen in Q4 2020 and held it in 1 quarter.
  • Thompson Siegel & Walmsley's Axogen position peaked at $50K in Q4 2020.
  • 123 funds tracked by Wall St. Rank held Axogen as of Q1 2021.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2021, filed 7 May 2021.